These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30463919)

  • 1. Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.
    Garrido JL; Prescott J; Calvo M; Bravo F; Alvarez R; Salas A; Riquelme R; Rioseco ML; Williamson BN; Haddock E; Feldmann H; Barria MI
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.
    Engdahl TB; Kuzmina NA; Ronk AJ; Mire CE; Hyde MA; Kose N; Josleyn MD; Sutton RE; Mehta A; Wolters RM; Lloyd NM; Valdivieso FR; Ksiazek TG; Hooper JW; Bukreyev A; Crowe JE
    Cell Rep; 2021 May; 35(5):109086. PubMed ID: 33951434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
    Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
    Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.
    Schountz T; Quackenbush S; Rovnak J; Haddock E; Black WC; Feldmann H; Prescott J
    J Virol; 2014 Aug; 88(15):8319-31. PubMed ID: 24829335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of ribavirin against Andes virus infection.
    Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
    PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pathogenesis between Andes virus strains CHI-7913 and Chile-9717869in Syrian Hamsters.
    Warner BM; Sloan A; Deschambault Y; Dowhanik S; Tierney K; Audet J; Liu G; Stein DR; Lung O; Buchanan C; Sroga P; Griffin BD; Siragam V; Frost KL; Booth S; Banadyga L; Saturday G; Scott D; Kobasa D; Safronetz D
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33627395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological assays for the detection of human andes hantavirus infections based on its yeast-expressed nucleocapsid protein.
    Schmidt J; Meisel H; Capria SG; Petraityte R; Lundkvist A; Hjelle B; Vial PA; Padula P; Krüger DH; Ulrich R
    Intervirology; 2006; 49(3):173-84. PubMed ID: 16428893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus.
    Vial PA; Valdivieso F; Calvo M; Rioseco ML; Riquelme R; Araneda A; Tomicic V; Graf J; Paredes L; Florenzano M; Bidart T; Cuiza A; Marco C; Hjelle B; Ye C; Hanfelt-Goade D; Vial C; Rivera JC; Delgado I; Mertz GJ;
    Antivir Ther; 2015; 20(4):377-86. PubMed ID: 25316807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential CD4 T Regulatory Cell Phenotype Induced by Andes Hantavirus Glycoprotein.
    Saavedra F; Garrido JL; Fuentes-Villalobos F; Calvo M; Riquelme R; Rioseco ML; Chahín C; Ferreira L; Alvarez R; Nova-Lamperti E; Barria MI
    Front Cell Infect Microbiol; 2020; 10():430. PubMed ID: 32984065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
    Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
    J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.
    Engdahl TB; Binshtein E; Brocato RL; Kuzmina NA; Principe LM; Kwilas SA; Kim RK; Chapman NS; Porter MS; Guardado-Calvo P; Rey FA; Handal LS; Diaz SM; Zagol-Ikapitte IA; Tran MH; McDonald WH; Meiler J; Reidy JX; Trivette A; Bukreyev A; Hooper JW; Crowe JE
    Elife; 2023 Mar; 12():. PubMed ID: 36971354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus.
    Martinez VP; Padula PJ
    J Med Virol; 2012 Jan; 84(1):87-95. PubMed ID: 22095538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
    Haese N; Brocato RL; Henderson T; Nilles ML; Kwilas SA; Josleyn MD; Hammerbeck CD; Schiltz J; Royals M; Ballantyne J; Hooper JW; Bradley DS
    PLoS Negl Trop Dis; 2015; 9(6):e0003803. PubMed ID: 26046641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.
    Manigold T; Mori A; Graumann R; Llop E; Simon V; Ferrés M; Valdivieso F; Castillo C; Hjelle B; Vial P
    PLoS Pathog; 2010 Feb; 6(2):e1000779. PubMed ID: 20174562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.